Live Breaking News & Updates on Armata Pharmaceuticals Stock Performance

Stay updated with breaking news from Armata pharmaceuticals stock performance. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Short Interest Update

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 15th, there was short interest totalling 800 shares, a decline of 92.5% from the April 30th total of 10,700 shares. Approximately 0.0% of the shares of the stock are short sold. Based […] ....

Armata Pharmaceuticals Stock Performance , Armata Pharmaceuticals Inc , Armata Pharmaceuticals , Institutional Investors Weigh In On Armata Pharmaceuticals , Securities Exchange Commission , News Ratings For Armata Pharmaceuticals Daily , Seacrest Wealth Management , Get Free Report , Crest Wealth Management , Free Report , Armata Pharmaceuticals Daily ,

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Posts Quarterly Earnings Results, Misses Expectations By $0.41 EPS

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Posts Quarterly Earnings Results, Misses Expectations By $0.41 EPS
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Armata Pharmaceuticals Stock Performance , Securities Exchange Commission , Earnings History For Armata Pharmaceuticals , Armata Pharmaceuticals , Seacrest Wealth Management , News Ratings For Armata Pharmaceuticals Daily , Armata Pharmaceuticals Inc , Get Free Report , Crest Wealth Management , Free Report , Armata Pharmaceuticals Daily ,

Armata Pharmaceuticals (NYSEAMERICAN:ARMP) Receives "Buy" Rating from HC Wainwright

HC Wainwright reissued their buy rating on shares of Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Free Report) in a research report released on Friday morning, Benzinga reports. They currently have a $7.00 price target on the stock. Armata Pharmaceuticals Stock Performance NYSEAMERICAN ARMP opened at $3.91 on Friday. The company has a market cap of $141.35 million, […] ....

Armata Pharmaceuticals Inc , Armata Pharmaceuticals , Armata Pharmaceuticals Company Profile , News Ratings For Armata Pharmaceuticals Daily , Northern Trust Corp , Renaissance Technologies , Armata Pharmaceuticals Stock Performance , Vanguard Group Inc , Free Report , Street Group , Get Free Report , Armata Pharmaceuticals Daily ,

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Short Interest Up 688.3% in July

Armata Pharmaceuticals, Inc. (NYSEAMERICAN:ARMP) Short Interest Up 688.3% in July
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

Armata Pharmaceuticals Inc , News Ratings For Armata Pharmaceuticals Daily , Armata Pharmaceuticals Stock Performance , Northern Trust Corp , Renaissance Technologies , Vanguard Group Inc , Institutional Investors Weigh In On Armata Pharmaceuticals , Armata Pharmaceuticals , Get Free Report , Trust Corp , Street Group , Vanguard Group , Armata Pharmaceuticals Daily ,

Armata Pharmaceuticals (ARMP) to Release Earnings on Wednesday

Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Get Free Report) is scheduled to issue its quarterly earnings data on Wednesday, August 9th. Armata Pharmaceuticals (NYSEAMERICAN:ARMP – Get Free Report) last posted its quarterly earnings data on Thursday, May 11th. The company reported ($0.40) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.29) by ($0.11). The […] ....

Earnings History For Armata Pharmaceuticals , Armata Pharmaceuticals Inc , Armata Pharmaceuticals , Institutional Investors Weigh In On Armata Pharmaceuticals , News Ratings For Armata Pharmaceuticals Daily , Vanguard Group Inc , Renaissance Technologies , Armata Pharmaceuticals Stock Performance , Northern Trust Corp , Get Free Report , Trust Corp , Jane Street Group , Armata Pharmaceuticals Daily , Nyseamerican Armp ,